Pfizer and 3SBio conclude licensing deal for SSGJ-707
Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the development, production…
Oncology
-
-
GSK’s Blenrep combos approved for multiple myeloma in EU
GSK has secured approval in the European Union (EU) for Blenrep combinations to treat adults with relapsed or refractory multiple…
-
Janssen’s Darzalex new indication gains EC approval for SMM
The European Commission (EC) has approved the Johnson & Johnson company Janssen-Cilag International’s new indication for Darzalex Faspro (daratumumab) subcutaneous…
-
GSK’s Blenrep faces setback as FDA cancer committee votes against approval
The US Food and Drug Administration’s (FDA’s) Oncologic Drugs Advisory Committee (ODAC) has voted against the benefit/risk profile of GSK’s Blenrep (belantamab…
-
Sino Biopharma spends $951m to acquire China-based LaNova Medicines
Hong Kong-listed Sino Biopharmaceutical will acquire China-based oncology specialist LaNova Medicines in a deal that will not exceed $951m, representing…
-
EC approves BeOne’s Tevimbra for nasopharyngeal carcinoma
BeOne Medicines has secured approval from the European Commission (EC) for Tevimbra (tislelizumab) to be used along with gemcitabine and…
-
IGI and AbbVie sign licence deal for cancer and autoimmune therapy
Ichnos Glenmark Innovation subsidiary IGI Therapeutics has signed an exclusive licensing agreement with AbbVie for ISB 2001, a cluster of…
-
CTO East Coast 2025: Global oncology cell therapy market to hit $25bn by 2031
According to GlobalData analysis, currently marketed and pipeline cell therapy assets in oncology will generate sales of around $25bn by…
-
Lupin and Zentiva in licence and supply deal for Certolizumab Pegol
Zentiva Group has entered into a licence and supply agreement with pharmaceutical company Lupin for the commercialisation of the latter’s…
-
Swissmedic approves IFINWIL for children with high-risk neuroblastoma
Norgine has announced that Swissmedic has approved the registration of IFINWIL (eflornithine) as a monotherapy for treating paediatric patients with…
